CLA may help the body preferentially use fat for energy instead of storing it
While transdermal patch delivery systems are under investigation, all commercially available GLP-1 therapies require subcutaneous injection (semaglutide, liraglutide, dulaglutide, tirzepatide) or oral administration (Rybelsus)
Semaglutide is a GLP-1 receptor agonist - designed to act on GLP-1 receptors to support appetite regulation and slow gastric emptying
Research has revealed several pathways in which gut microbiota alterations in GD may contribute to a decreased level of central serotonin, thereby increasing the susceptibility to depression
For weight management, these medications are typically prescribed for people with a BMI of 30 or higher, or 27 or higher with a weight-related health condition like diabetes, obstructive sleep apnea or high blood pressure
But at the moment: Oral tanning supplements are unregulated, unproven and potentially unsafe